# The Effect of Dietary Management and Cysteine Supplementation on Growth Parameters and Biochemical Control for Pediatric Qatari Patients Affected with Classical B6 Non-responsive Homocystinuria.

> **NCT06622577** · NA · NOT_YET_RECRUITING · sponsor: **Hamad Medical Corporation** · enrollment: 50 (estimated)

## Conditions studied

- Classical Homocystinuria

## Interventions

- **DIETARY_SUPPLEMENT:** Cysteine

## Key facts

- **NCT ID:** NCT06622577
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622577, "The Effect of Dietary Management and Cysteine Supplementation on Growth Parameters and Biochemical Control for Pediatric Qatari Patients Affected with Classical B6 Non-responsive Homocystinuria.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06622577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*